- About us
- A new Institute dedicated to combating leukemia
- Medical-scientific program
- History of Hematology on the Saint-Louis Campus
- The Leukemia Institute’s governance
- Press
- Contact us
- Our news
- Profile of Valéria Bisio, Research Officer
- Creation of a Hemato-Oncogenetics Unit
- Profile of Alice Gros, a peer-support patient
- Winners of the Leukemia Institute’s first call for projects
- Profile of Julien Calvo, researcher
- Support us
- Join us
- You are
- Patients and relatives
- To be cared for and supported
- Become an expert patient
- Discover the Leukemia Institute
- Researchers
- Research
- Clinical trials
- Discover the Leukemia Institute
- Healthcare professionals
- Refer a patient
- Our clinical research
- Discover the Leukemia Institute
- Industry partners
- Discover the Leukemia Institute
- Translational research
- Donors
- Support us
- Discover the Leukemia Institute
- Care
- Patient care
- Being Treated at the Leukemia Institute
- Cancer treatments
- Supportive Care
- Open Multidisciplinary Meetings
- Our clinical services
- Saint-Louis Hospital – Department of adult hematology
- Saint-Louis Hospital – Hematology Transplant Unit
- Saint-Louis Hospital – Department of Pharmacology and Clinical Investigations
- Saint-Louis Hospital – Adolescent and Young Adult Unit
- Saint-Louis Hospital – Outpatient Hemato-oncogenetics Unit
- Saint-Louis Hospital – Department of senior hematology
- Robert-Debré Hospital – Department of pediatric hematology and immunology
- Necker Hospital – Department of Adult Hematology
- Cochin–Port Royal Hospital – Department of clinical hematology
- Avicenne Hospital – Department of clinical hematology and cell therapy
- Our medical laboratories
- Hematology Medical Laboratory, Michaela Fontenay
- Hematology Medical Laboratory, Jean Soulier
- Molecular Genetics Unit, Hélène Cavé
- Hematology Medical Laboratory, Vahid Asnafi
- Patient information
- Acute Myeloid Leukemias
- Acute Lymphoblastic Leukemias
- Myeloproliferative Neoplasms
- Myelodysplastic Syndrome
- Cancer treatments
- Supportive Care
- Psychological Support
- Research
- Our research teams
- Hugues de Thé’s team – Molecular pathology
- Raphaël Itzykson’s team – Functional precision medicine for leukemia
- Michaela Fontenay’s team – Normal and pathological hematopoiesis
- Françoise Pflumio’s team – Niche, Cancer, and Radiation in Hematopoiesis
- Sylvie Méléard’s team – Population Evolution and Interaction Particle Systems
- David Michonneau’s team – Translational Immunology in Immunotherapy and Hematology (TIGITH)
- Lina Benajiba’s team – Identification and targeting of extrinsic regulators of myeloid malignancies
- Karl Balabanian’s team – Lymphoid niches, Chemokines and Immuno-hematological syndromes
- Alexandre Puissant’s team – Molecular Mechanisms of Acute Myeloid Leukemia Development
- Stéphane Giraudier’s team – Chronic Myeloid Malignancies, Microenvironment & Translational Research
- Diana Passaro’s team – Leukemia & Niche Dynamics
- Camille Lobry’s team – Genetic and Epigenetic control of Normal and Malignant Hematopoiesis
- Jean Soulier’s team – Stem cell dysfunction and secondary AML
- Sylvie Chevret’s team – Biostatistics and clinical epidemiology
- Our technological platforms
- Our clinical research
Accueil Stéphane Giraudier’s team – Chronic Myeloid Malignancies, Microenvironment & Translational ResearchStéphane Giraudier’s team – Chronic Myeloid Malignancies, Microenvironment & Translational Research
...Stéphane Giraudier
Team leader
Institut de recherche Saint-Louis
Research themes
Our team develops translational models to improve the understanding and treatment of Myeloproliferative Neoplasms (MPNs): patient samples, patient-derived cell lines, induced pluripotent stem cells (iPSCs), murine models (transgenic and transplantable), primary cell cultures, next-generation sequencing, lentiviral transduction, cell sorting, and microfluidic-based single-cell DNA analysis. Ongoing projects focus on modeling normal and JAK2V617F-mutated stress hematopoiesis, exploring the bone marrow microenvironment in MPN patients, and studying how clonal selection impacts clinical outcome and therapy response.
- Myeloproliferative Neoplasms (MPNs)
Research areas
We study the impact of the bone marrow niche in MPNs, particularly its role in regulating mutated hematopoiesis and contributing to treatment resistance.
We investigate clonal dynamics in MPNs under therapeutic pressure and stress conditions, aiming to understand how aggressive subclones emerge and expand.
Featured research projects
Microenvironmental role in MPN progression
Deciphering stromal-tumor interactions and their contribution to disease evolution and therapeutic escape.
Bruno Cassinat & Laura Velazquez
Interferon response and immunity in MPNs
In vitro and in vivo modeling of IFNα response in JAK2V617F context and investigation of immune-mediated therapeutic mechanisms.
Stéphane Giraudier
Clonal selection under therapy
Monitoring clonal evolution in treated patients and exploring senescence and senolysis as therapeutic targets in MPNs.
Nabih Maslah & Jean-Jacques Kiladjian
Stéphane Giraudier's team members
Stéphane GiraudierTeam Leader, Full Professor (PU-PH)Jean-Jacques KiladjianFull Professor (PU-PH)Bruno CassinatHospital Practitioner (PH)Pierre FenauxFull Professor (PU-PH)Nabih MaslahAssociate Professor (MCU-PH)Sarah Awan-ToorResearch EngineerLaura VelazquezResearch Scientist (CR1)Bochra MlayahResearch AssistantEmmanuelle VergerResearch EngineerLiu DuanyaPhD StudentPierre PainsecResearch AssistantDiego ElrioAssistant Hospital-University Practitioner (AHU)Jimena CastorenaResearch EngineerNelly BosselutPHLouis DrevonPHScientific publications
Nabih Maslah & al, Nat Commun., 2025
JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasmsRead the publicationGanesan & al, JCI Insight, 2024
Comprehensive analysis of mesenchymal cells reveals a dysregulated TGF-β/WNT/HOXB7 axis in patients with myelofibrosisRead the publicationGou & al, Blood Cancer J, 2024
Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasmsRead the publicationStay up to date by subscribing to the institute's newsletter
- Discover the Leukemia Institute
- Translational research
- Our clinical research
- Clinical trials
- Become an expert patient
- To be cared for and supported
- A new Institute dedicated to combating leukemia